The Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA) program is an innovative, patient-centered system of care developed by the University Hospitals Harrington Heart ...

New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful ...

Although promising, the clinical impact of video conferencing between primary and secondary care specialists lacks trial evidence. We conducted a two-arm RCT (clinicaltrials.gov: NCT05268081) to ...

The American College of Lifestyle Medicine (ACLM) has published the first clinical practice guideline to put lifestyle interventions at the forefront of type 2 diabetes and prediabetes care.

Clinical guidelines recommend basic carbohydrate counting (BCC), or similar methods to improve carbohydrate estimation skills and to strive for higher consistency in carbohydrate intake potentially ...

If you have type 2 diabetes and experience fatigue, you know it isn’t the kind of tiredness that clears up with a nap. Chronic fatigue is common for people with diabetes, and a variety of factors can ...

If youre consistently taking your type 2 diabetes medication but your A1C still isn't on target (less than 7 percent for most people with diabetes), you may be dealing with a phenomenon called ...

The US Food and Drug Administration (FDA) has cleared the Omnipod 5 for use by people aged 18 and older with type 2 diabetes, a first for any automated insulin delivery (AID) system. The Omnipod 5 ...

A number of healthy diets have been linked to a lower risk of type 2 diabetes, no matter a person’s ethnic background. Researchers suggest that these eating habits, which emphasize fruits, vegetables, ...

How Does It Work for Type 2 Diabetes? Jardiance lowers blood sugar. Normally, the kidneys filter sugar in a way that keeps it in the bloodstream rather than allowing it to leave the body through the ...

Medicines called glucagon-like peptide-1 (GLP-1) receptor agonists have changed how type 2 diabetes is treated. GLP-1 medicines, like semaglutide (Rybelsus), work by acting like the body’s natural GLP ...